Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline
- 12 August 2018
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 243 (12) , 995-1003
Abstract
Pulmonary arterial hypertension (PAH) in humans manifests as a chronic process. However, PAH induced by high-dose monocrotaline (MCT) in animals occurs as a subacute process. To establish a chronic PAH model, rats were randomly divided into three groups, control (ctrl), single injection (SI), and twice injection (TI) groups. Rats in the SI group received a single intraperitoneal injection of 40 mg/kg MCT on day 0. Rats in the TI group received twice injections of 20 mg/kg MCT on days 0 and 7. Survival percentage, characteristic changes of pulmonary arterial variables, and right ventricular features were evaluated. Thirty-five days after the first MCT injection, survival percentage in TI group was higher than that in the SI group. The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor α (TNFα), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first MCT injection. The rats in the SI and TI groups exhibited higher right ventricle end diastolic diameter (RVEDD) and lower adjusted pulmonary artery acceleration time (PAAT/HR), tricuspid annular plane systolic excursion (TAPSE), cardiac output (CO) and right ventricle fractional shortening (RVFS) when compared with controls. However, mPAP, RVHI, TAPSE, PAAT/HR, CO, TNFα, and IL-6 were lower and RVEDD were higher in the TI group than in the SI group. Pulmonary macrophage infiltration and right ventricle (RV) fibrosis were lower in TI than SI groups. The cardiomyocyte cross-sectional area and the beta myosin heavy chain (MYH7) mRNA level of RV were lower in TI than SI, whereas alpha myosin heavy chain (MYH6) was increased. These results show that two intraperitoneal injections of 20 mg/kg MCT with seven days interval could induce a model similar to chronic PAH with increased survival percentage in rats.Impact statement: We demonstrated previously that a single intraperitoneal injection of 40 mg/kg MCT produced a subacute, not chronic, PAH model in rats, and the short survival periods of these rats did not represent adequately the chronic PAH seen in humans. To overcome this limitation, in this study, the single dose of 40 mg/kg MCT was divided into twice injections of 20 mg/kg with an interval of seven days. This modified administration of MCT produced an animal model much more similar to chronic PAH with prolonged survival and characteristic changes of structures and function in pulmonary arteries and right ventricles.Keywords
Funding Information
- National Natural Science Foundation of China (81270111)
- National Natural Science Foundation of China (81570446)
This publication has 26 references indexed in Scilit:
- A Comprehensive Review: The Evolution of Animal Models in Pulmonary Hypertension Research; Are We there Yet?Pulmonary Circulation, 2013
- The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in ratsHeart and Vessels, 2013
- Effects of Trimethoxystilbene on Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle CellsCell Biochemistry and Biophysics, 2012
- Assessment of the Endothelial Functions in Monocrotaline-induced Pulmonary HypertensionClinical and Experimental Hypertension, 2012
- The monocrotaline model of pulmonary hypertension in perspectiveAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Fibrosis of pulmonary vascular remodeling in carotid artery-jugular vein shunt pulmonary artery hypertension model of ratsEuropean Journal of Cardio-Thoracic Surgery, 2011
- Effects of Atorvastatin and Losartan on Monocrotaline-Induced Pulmonary Artery Remodeling in RatsClinical and Experimental Hypertension, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Genotoxicity and morphological changes induced by the alkaloid monocrotaline, extracted from Crotalaria retusa, in a model of glial cellsToxicon, 2010
- Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cellsProteomics, 2005